Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)

OBJECTIVE: Cell-free DNA (cfDNA) is an attractive cancer biomarker, as it is thought to reflect a component of the underlying genetic makeup of the tumor and is readily accessible in serial fashion. Because chemotherapy regimens are expected to act rapidly on cancer and cfDNA is cleared from the blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Patsch, Katherin, Matasci, Naim, Soundararajan, Anjana, Diaz, Patricia, Agus, David B., Ruderman, Daniel, Gross, Mitchell E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521434/
https://www.ncbi.nlm.nih.gov/pubmed/31092276
http://dx.doi.org/10.1186/s13104-019-4312-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521434/
https://www.ncbi.nlm.nih.gov/pubmed/31092276
http://dx.doi.org/10.1186/s13104-019-4312-2

Ejemplares similares